Bank of America’s Biostage, Inc. Common Stock BSTG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-143
Closed 7482
2016
Q4
$0 Sell
143
-17
-11% -$15 ﹤0.01% 7579
2016
Q3
$0 Sell
160
-6,982
-98% -$7.51K ﹤0.01% 7556
2016
Q2
$8K Sell
7,142
-2,858
-29% -$4.61K ﹤0.01% 6584
2016
Q1
$18K Sell
10,000
-10,250
-51% -$17K ﹤0.01% 6186
2015
Q4
$45K Buy
20,250
+10,250
+103% +$14.3K ﹤0.01% 6088
2015
Q3
$8K Hold
10,000
﹤0.01% 6658
2015
Q2
$14K Sell
10,000
-500
-5% -$1.22K ﹤0.01% 6487
2015
Q1
$35K Buy
10,500
+500
+5% +$1.7K ﹤0.01% 5818
2014
Q4
$32K Hold
10,000
﹤0.01% 6577
2014
Q3
$81K Sell
10,000
-17,748
-64% -$145K ﹤0.01% 6177
2014
Q2
$290K Buy
27,748
+27,745
+924,833% +$236K ﹤0.01% 5184
2014
Q1
$0 Sell
3
-212
-99% -$1.26K ﹤0.01% 8334
2013
Q4
$1K Buy
+215
New +$1.01K ﹤0.01% 7781

Other funds holding BSTG

Bank of America's BSTG Position: Q1 2017 in Review

Bank of America sold out of Biostage, Inc. Common Stock (BSTG) in Q1 2017, closing a stake of 143 shares.

Bank of America first reported a position in BSTG in Q4 2013 and held it in 13 quarters. The position peaked at $290K in Q2 2014. 24 funds tracked by Wall St. Rank hold BSTG as of Q1 2017.

  • Bank of America reported no remaining Biostage, Inc. Common Stock position as of Q1 2017 after selling out during the quarter.
  • Bank of America sold 143 Biostage, Inc. Common Stock shares in Q1 2017.
  • Bank of America first reported a position in Biostage, Inc. Common Stock in Q4 2013 and held it in 13 quarters.
  • Bank of America's Biostage, Inc. Common Stock position peaked at $290K in Q2 2014.
  • 24 funds tracked by Wall St. Rank held Biostage, Inc. Common Stock as of Q1 2017.

Based on Bank of America's 13F filing for Q1 2017, filed 15 May 2017.